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Introduction
Tissue factor (TF) is an initiator in physiologic
coagulation and pathologic thrombosis.1,2 We had
observed that the elevation of TF in plasma was
associated with the onset of acute cerebrocardiac
thrombotic diseases.2 TF not only participates in the
activation of blood coagulation, but also can mediate
a series of cell responses to proinflammatory factors in
the inflammation process.1 Considerable evidence has
been accumulated to indicate that there is a
coagulation–inflammation network in vivo in which
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Conclusion: CINN is able to attenuate TNF_-induced TF expression of vascular endothelial cells by inhibiting
NF-gB activation. [J Chin Med Assoc 2006;69(5):207–212]
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the expression of TF in activated vascular endothelial
cells may present a major link between inflammation
and thrombosis.3
Vascular endothelial cells participate in the
regulation of hemostasis by controlling the expression
of procoagulant factors as well as anticoagulant factors.
TF is of major biologic significance for the procoagulant
properties of endothelial cells and monocytes when
they are activated by proinflammation cytokines, and
functions as a membrane glycoprotein receptor that
specifically binds coagulation factor VII or VIIa.
Production of TF in endothelial cells and monocytes
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has been associated with coagulopathy and thrombosis
in irritated vessels in a number of diseases, such as
septic shock, atheroma, and disseminated intravascular
coagulation. Many pathologic agents are important
in causing cell TF expression. Among them,
proinflammatory tumor necrosis factor alpha (TNF_)
is most strongly implicated in vascular disease.
Cinnamic acid (CINN) is the major component
extracted from the Chinese herb cinnamon. CINN is
demonstrated to be able to exert cytoprotective and
antioxidant effects on endothelial cells, and anti-tumor
effects in experimental animal models.4,5 However,
whether it affects the procoagulant activity of
endothelial cells remains unclear.
In this study, we investigated the effects of CINN
on the expression of TF induced by TNF_ in human
umbilical vein endothelium-derived cell line ECV304
and the role of NF-gB in the down-regulation of TF
expression caused by CINN.
Methods
Materials
Citrated normal human plasma was obtained from
Changsha Red Cross Blood Center, Hunan, China.
Human polyclonal anti-TF antibody was generously
provided by Dr. J.H. Morrissey (Department of
Biochemistry, College of Medicine/University of
Illinois, Urbana-Champaign, IL, USA). DEGR-FVIIa
was purchased from American Diagnostica Inc.
(Stamford, CT, USA). RPMI-1640 cell culture
medium and fetal bovine serum were from Gibco
(Gaithersburg, MD, USA). Recombinant human
TNF_ came from Dingguo (Beijing, China).
Glyceraldehyde-3 phosphate dehydrogenase
(GAPDH) cDNA probe was purchased from Sangon
(Shanghai, China). Classic total RNA minipreps kit
and diethylpyrocarbonate (DEPC) were purchased
from Hyclone-Pierce (South Logan, UT, USA).
NF-gB p65 antibody kit for immunohistochemistry
and I-gB antibody kit were purchased from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA, USA),
and sodium dodecyl sulfate (SDS) and dithiothreitol
(DTT) were purchased from Promega (Madison,
WI, USA).
Culture of human umbilical vein endothelial
cells
A human umbilical endothelium-derived cell line
(ECV304) from the Chinese Type Culture Collection
(Wuhan, China) was used in this study. The cells were
cultured in RPMI-1640 supplemented with 10% fetal
bovine serum and 50 μg/mL gentamycin, under an
atmosphere of 95% air and 5% CO2. Cells were
maintained by subculturing 2 or 3 times per week.
Before experiments, cells were washed twice with
RPMI and cell viability was checked by trypan blue
exclusion (viable cells > 95%).
Determination of ECV304 TF activity
After incubation of the cells (24-well plates, 1.5 × 105
cells/well) with TNF_ in the presence or absence of
CINN, the cells were washed 3 times with D-Hank’s
solution and scrape-harvested into 300 μL of
D-Hank’s. The cells were frozen in liquid nitrogen
and thawed in a water bath at 37°C for 3 cycles. The
TF activity of the cell lysate was determined with
1-stage clotting assay that measures total cellular
procoagulant activity as described previously.6 Briefly,
50 μL of lysate was added to 50 μL of citrate-
anticoagulated pooled human normal plasma or factor
VII-deficient plasma, and clotting was initiated by the
addition of 50 μL of 25 mmol/L CaCl2. The clotting
time at 37°C was recorded. Each sample was run in
duplicate. TF procoagulant activity (PCA) was
quantitated by reference to standard curves constructed
with rabbit brain thromboplastin as the TF source.
The TF activity of 1 μL thromboplastin was arbitrarily
defined as 1 × 103 mU. The standard curves were linear
in the range of 0–1000 mU of TF activity (r2 = 0.99).
The coagulant activity measured with this clotting
assay reflected TF activity of cell lysate, as indicated by
the lack of procoagulant activity from ECV304 when
polyclonal anti-TF antibody and DEGR-VIIa were
applied in the clotting assay.
Analysis of TF mRNA
Total RNA of ECV304 was prepared by Classic total
RNA minipreps kit (Hyclone-Pierce) according to the
manufacturer’s manual. The purity and integrity of
total RNA were confirmed by the absorbance ratio of
A260/A280 ( > 1.8) and agarose electrophoresis.
The ECV304 cells were treated with TNF_ in the
presence or absence of CINN. TF mRNA was assessed
using the RT-PCR method.7 Briefly, total RNA (1 μg)
was reverse transcripted with the superscript
preamplification system (Gibco BRL, Gaithersburg,
MD, USA) using random hexamer primers, and the
reverse-transcripted cDNA was then amplified by PCR
using the primers prepared based on the mRNA
sequences of TF or GAPDH. GAPDH gene is a
housekeeping gene that is not affected by the used
stimulants and was used as the control in this study.
The primers used for TF mRNA amplification were
the same as those described by Iochmann et al.8
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TF specific forward primer (5'-CTACTGTTTCA-
GTGTTCAAGCAGTGA-3') and reverse primer
(5'-CAGTGCAATATAGCATTTGCAGTAG C-3')
correspond to positions 759–784 and 1016–1041 of
TF cDNA, respectively, and amplify a 282-bp region
encompassing the 5th and 6th exons of TF. Primers
for amplifying GAPDH, 5'-GCTGGCGCTGAGTA-
CGTCGT-3' and 5'-GCTGGCGCTGAGTACGTCG
T-3', amplify a 475-bp fragment according to the
GAPDH sequence provided by GenBank. PCR was
performed for 35 cycles consisting of 50 seconds of
denaturation at 94°C, 50 seconds of annealing at 60°C,
and 1 minute of elongation at 72°C. The PCR products
were subjected to electrophoresis, and the DNA bands
on the gel were scanned and densitometrically quantified
with a HEMA Bio-Image analyzer (Hema Inc., Zhuhai,
China). The amount of TF mRNA was standardized
relative to the amount of GAPDH mRNA.
Western blot analysis
The ECV304 cells were washed once in phosphate-
buffered saline (PBS) and were lysed in ice-cold buffer
containing 50 mM Tris (pH 8.0), 110 mM NaCl,
5 mM EDTA, 1% Triton X-100, and 10 μg/mL
phenylmethylsulfonyl fluoride (PMSF). Protein
concentrations were determined using a Bio-Rad
assay. Fifty micrograms of cell lysates were boiled in
equal volumes of loading buffer (125 mM Tris-HCl,
pH 6.8, 4% SDS, 20% glycerol, 2% ` -mercaptoethanol,
and 0% bromophenol blue) and were subjected to
5–12% gradient gel electrophoresis in Tris/glycine
buffer. Following electrophoretic separation, proteins
on the gel were transferred to nitrocellulose membranes
(Novex) using the Novex X Mini Gel system (Promega)
for Western immunoblotting. Membranes were
blocked with 5% nonfat dried milk in Tris-buffered
saline (TBS) and 0.1% Tween 20 for 1 hour and then
incubated with a rabbit polyclonal anti-IgB-_ antibody
at a dilution of 1:400 overnight at 4°C. After washing
twice with TBS containing 0.1% Tween 20, peroxidase-
conjugated antirabbit immunoglobulin G (IgG)
antibody was applied at a dilution of 1:300 for 2 hours
at room temperature. Blots were washed in TBS
containing 0.1% Tween 20 twice over 30 minutes and
were incubated in diaminobenzidine for color
development.
Immunohistochemical analysis
Cells were grown on coverslip glass for 24 hours as
described above. TNF_ (1,000 U/mL) was then
added to culture wells for treatment. The culture
media were aspirated away after 24 hours of stimulation,
and the cells on coverslips were fixed with
paraformaldehyde. The cells on coverslips were then
treated with chilled H2O2, washed with PBS, and
blocked with PBS containing 10% goat serum. For
immunostaining, the cells on coverslips were incubated
with a monoclonal antihuman NF-gB antibody
(200 μg/mL) at room temperature, washed again,
and further incubated with biotinylated antirabbit
IgG antibody. After repeated washing, a strepavidin–
biotin complex system with diaminobenzidene as
chromogen was used for color development. Sections
were finally counterstained with hematoxylin and
examined under a light microscope.
Statistical analysis
Results are expressed as mean ± SD. Comparison
between data from control and treatment groups was
performed by Mann-Whitney rank-sum test.
Correlation between data from different groups was
analyzed with Spearman rank correlation. Results were
considered statistically significant at p less than 0.05.
Results
Effects of CINN on TF activity of ECV304
stimulated with TNF_
When compared with the control, a corresponding
dose increase in TF activity was observed on ECV304
stimulated with increasing concentrations (from 250
to 1,000 U/mL) of TNF_ (n = 6, r = 0.992, p < 0.01)
in the experimental group. CINN at 500 μg/mL
inhibited the stimulatory effects of TNF_ on TF
activity of ECV304. In the used concentrations of
CINN (32.625–500 μg/mL), the cell surface TF
activity was decreased in a concentration-dependent
fashion (Figure 1) (n = 6, r = –0.953, p < 0.01).
Figure 1. Effects of different concentrations of cinnamic acid (C)
on TF activity stimulated with TNF_ (T, 1,000 U/mL) in ECV304.
*p < 0.01, versus control; #p < 0.05, ##p < 0.01, versus TNF_.
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Effects of CINN on ECV304 TF mRNA
expression induced by TNF_
After 2 hours of TNF_ treatment, 1,000 U/mL of
TNF_ markedly induced TF mRNA expression. CINN
significantly inhibited TF mRNA expression induced
by TNF_. These effects of CINN on the TF mRNA
expression appear to correlate well with those CINN
exhibited on the total TF activity in ECV304, as
shown in Figure 2.
Dynamic observation of the changes of I-gB
protein in cytoplasm
The dynamic observation of the changes of I-gB
protein in cytoplasm showed that I-gB protein began
decreasing at 15 minutes after TNF_ (1,000 U/mL)
was added to ECV304 (n = 3, p < 0.05); I-gB
decreased to its lowest point at 45 minutes and started
recovery at 60 minutes and completely returned to the
basic level at about 120 minutes (Figure 3). Figure 4
shows CINN might alleviate the decrement of I-gB
protein in cytoplasm induced by TNF_.
The effect of CINN on the translocation of
NF-gB from the cytoplasm to the nucleus
ECV304 cells without TNF_ treatment were not
stained in the nucleus after immunostaining. In
contrast, the nuclei of the cells treated with TNF_ for
45 minutes showed highly positive staining. The cells
pretreated with CINN 15 minutes before the addition
of TNF_ to the cell culture showed much weaker
staining compared with the cells treated with TNF_
alone (Figures 5 and 6) (n = 4, p < 0.01).
Discussion
Numerous experimental and clinical studies have
shown a variety of detrimental stimulations which
could cause an inflammation reaction that was
frequently followed by hypercoagulation.9,10 Although
the mechanism by which inflammation and
coagulation are linked is not fully elucidated, it is
speculated to be related to the changes of the
coagulation system, anticoagulation system,
fibrinolysis system, antifibrinolysis and platelets, etc.
Those system changes in turn influence the functions
of vascular endothelium cells (VEC), especially the
TF expression of VEC. Little TF is expressed in VEC
under physiologic conditions, but when VEC is
injured or challenged with inflammatory factors, a
high level of TF might be expressed. The TF expression
on VEC may be relevant to numerous conditions
related to clinical medicine.
Figure 2. Effects of different concentrations of cinnamic acid (C)
and TNF_ (T) on TF mRNA expression detected by RT-PCR.
Figure 3. Changes of I-gB in cytoplasm induced by TNF_: (A)
represents the results by Western blot analysis; (B) represents
the mean of 3 experiments. *p < 0.01, versus control.
Figure 4. Inhibitory effect of cinnamic acid (C) on the decrement
of I-gB protein in cytoplasm induced by TNF_ (T).
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Proinflammatory cytokines play a critical role
during an inflammatory reaction.11 Inflammatory
cytokines including TNF_, interleukin-1 (IL-1) and
IL-8 may induce ECV304 and monocytes to express
TF, and play an important role in TF expression of
atherosclerosis plaque.12 Numerous studies have
demonstrated that most cardiocerebral vascular
thrombotic events are related to TF procoagulatory
activity released from the broken atherosclerotic
plaque. Therefore, the inhibition of coagulation
initiated by inflammatory cytokines is an important
strategy for prevention and treatment of thrombotic
diseases.
CINN is known to exert cytoprotective and
antioxidant effects on endothelial cells and is widely
used in clinical practice of traditional Chinese medicine.
These findings on CINN prompt us to investigate the
effect of CINN on the procoagulant activity of human
umbilical vein endothelial cells (HUVECs) stimulated
with TNF_. The results of the present study showed
that CINN significantly inhibited the expression of TF
in ECV304 cells, and suggested that CINN does have
an antithrombotic effect.
There is a coagulation–inflammation network
formed by inflammatory factors and coagulant factors
and their interactions. The TF expression on VEC is
regulated by this coagulation–inflammation network.
The inflammatory cytokines such as TNF_ are
stimulators of TF expression on VEC. On the other
hand, TF belongs to the type II cytokine receptor
family and may mediate the signal transduction involved
in the inflammatory process. This study demonstrated
that CINN was able to inhibit TNF_-induced TF
expression on VEC, suggesting its potential anti-
inflammatory effect.
Figure 6. Comparison of integral optical density (IOD) of NF-gB.
The results represent the mean of 4 experiments. C = cinnamic
acid; T = TNF_. *p < 0.01, versus control.
Figure 5. Immunohistochemical analysis
showed NF-gB translocation induced by
TNF_ and the inhibitory effect of cinnamic
acid on the process. ? indicates NF-gB
that had translocated to nucleus. (A)
Control; (B) TNF_ (× 10); (C) TNF_ (× 100);
(D) cinnamic acid; (E) cinnamic acid +
TNF_.
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While the study conclusively demonstrated the
induction of TF expression in endothelial cells by
TNF_, it was not designed to assess the cellular
mechanisms for the inhibition of CINN on TF
expression in HUVECs. TNF_ has been shown to
increase the TF mRNA level in endothelial cells
predominantly by increasing transcription. In
addition, TNF_-mediated activation of protein kinase
C (PKC) was in general not required for NF-gB
activation or for protein expression in endothelial
cells. It is clearly explicated that the TNF_-induced
TF expression of ECV304 mainly involves PKC,
protein tyrosine kinase (PTK), and mitogen-activated-
protein kinase (MAPK) pathways, but a co-pathway
is exerted through NF-gB/I-gB. The inactivated
form of NF-gB is a heterodimer usually consisting of
2 subunits, the p65 and p50 proteins. In unstimulated
cells, NF-gB is found in the cytoplasm and is bound
to I-gB, which prevents NF-gB from entering the
nucleus. When these cells are stimulated by TNF_,
specific kinases phosphorylate I-gB, causing its rapid
degradation by proteasomes. The release of I-gB
from NF-gB/I-gB complex results in the passage of
NF-gB from cytoplasm to the nucleus, where it binds
to specific DNA sequences in the promoter regions
of target genes. The potential implication of NF-gB
activation in the TF expression involved in the
pathogenesis of atherosclerosis is an attractive
emerging idea, but there is evidence that intracellular
signaling pathways in endothelial cells, initiated by
diverse agonists that induce TF gene expression,
converge in a common pathway involving NF-gB.13,14
In the current study, the analysis of the TF mRNA
expression, together with the finding that the changes
of the amount of TF mRNA were transient and
positively correlated with that of the TF activity,
suggest that the inhibitory effect of CINN on TNF_-
induced TF expression in HUVECs was probably a
result of the interference of CINN in TF gene
transcription. In addition, we also found that CINN
could inhibit TNF_-induced TF expression of vascular
endothelium cells by blocking NF-gB activation.
High expression of TF by endothelial cells and
monocytes driven by pro-inflammatory substances,
such as TNF_, may be responsible for some thrombotic
diseases, and TF expression may also be involved in
some cancer diseases. Our present study showed that
CINN might influence the expression of TF locally,
suggesting that CINN might have potential application
in the prevention and therapy of systemic inflammation
in addition to acting as an anticoagulant agent in vivo.
However, the precise role of CINN in regulation of TF
expression requires further elucidation, since multiple
agonists are quickly generated and are present
simultaneously with TF during an inflammation-
associated thrombotic event.
In brief, the present study showed for the first time
that CINN strongly inhibits TNF_-induced TF
expression in endothelial cells. The results are favorable
to understand the antithrombotic effect of CINN, and
offer new therapeutic applications of CINN.
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